Report
Louis-Clément AZAIS d'UHART
EUR 108.58 For Business Accounts Only

Short term view - BIOMERIEUX : The moving average is supporting prices.

Peaks and troughs overlap, they still define a bullish trend but it could also be an exhaustion. The next target is at €156.30. The invalidation level is below €142.00.

Arguments :
- Prices are pulling back to the support level (previously a resistance). The rise will resume...
Underlying
BioMerieux SA

Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Louis-Clément AZAIS d'UHART

Other Reports on these Companies
Other Reports from Day By Day

ResearchPool Subscriptions

Get the most out of your insights

Get in touch